Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;37(5):407-417.
doi: 10.1002/da.22978. Epub 2019 Nov 28.

A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder

Affiliations
Review

A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder

Carly Johnco et al. Depress Anxiety. 2020 May.

Abstract

Objective: Beliefs that exposure with response prevention (ERP) is excessively distressing and will result in client dropout from treatment are commonly-cited reasons for clinicians not providing evidence-based treatment. This meta-analysis examined treatment attrition for ERP for youth with obsessive compulsive disorder (OCD) compared with other treatment modalities.

Method: A systematic literature search identified 11 randomized controlled trials (RCTs) comparing ERP to active or waitlist control conditions, 9 comparing pharmacotherapy to control, and 3 comparing ERP to pharmacotherapy for youth with OCD.

Results: Attrition rates were low for ERP (10.24%) compared to pharmacotherapy (17.29%), active control (e.g., relaxation, metacognitive therapy; 20.63%), and pill placebo (23.49%). ERP had lower risk of attrition compared to active control conditions (RR = 0.60; p = .02), and was not significantly different to waitlist (RR = 0.80; p = .59). In head-to-head trials, there was no difference between the risk of attrition from ERP and pharmacotherapy (RR = 1.26; p = .74). Of the pharmacotherapy trials, risk of attrition from serotonin reuptake inhibitors treatment was not significantly different compared to placebo (RR = 0.94; p = .76), with no difference between antidepressants and clomipramine (p = .19). Attrition from ERP was primarily for logistical reasons, compared to lack of efficacy for relaxation and/or adverse reactions from pharmacotherapy.

Conclusions: Attrition from ERP is low, and is generally lower than non-ERP interventions. Given favorable attrition and efficacy data, there is little justification for appropriately-trained clinicians not to offer ERP as a first-line treatment for youth with OCD.

Keywords: attrition; dropout; exposure; obsessive compulsive disorder; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Asbahr, F. R., Castillo, A. R., Ito, L. M., Latorre, M. R., Moreira, M. N., & Lotufo-Neto, F. (2005). Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44(11), 1128-1136. https://doi.org/10.1097/01.chi.0000177324.40005.6f
    1. Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: A controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 43(1), 46-62. https://doi.org/10.1097/00004583-200401000-00014
    1. Becker, C. B., Zayfert, C., & Anderson, E. (2004). A survey of psychologists' attitudes towards and utilization of exposure therapy for PTSD. Behaviour Research and Therapy, 42(3), 277-292. https://doi.org/10.1016/s0005-7967(03)00138-4
    1. Böhm, K., Förstner, U., Külz, A., & Voderholzer, U. (2008). Versorgungsrealität der Zwangsstörungen: Werden Expositionsverfahren eingesetzt? Verhaltenstherapie, 18(1), 18-24.
    1. Bolton, D., & Perrin, S. (2008). Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. Journal of Behavior Therapy and Experimental Psychiatry, 39(1), 11-22. https://doi.org/10.1016/j.jbtep.2006.11.002

MeSH terms

Substances

LinkOut - more resources